Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.

No Thumbnail Available
Authors
Besser, R.
Shields, Beverley
Hammersley, S.
Colclough, Kevin
McDonald, Timothy J.
Gray, Z.
Heywood, J. J. N.
Barrett, T. G.
Hattersley, Andrew T.
Issue Date
2013-05
Type
Multicenter Study
Research Support, Non-U.S. Gov't
Language
en
Keywords
Wessex Classification Subject Headings::Endocrinology::Diabetes
Research Projects
Organizational Units
Journal Issue
Alternative Title
Making the correct diabetes diagnosis in children is crucial for lifelong management. Type 2 diabetes and maturity onset diabetes of the young (MODY) are seen in the pediatric setting, and can be difficult to discriminate from type 1 diabetes. Postprandial urinary C-peptide creatinine ratio (UCPCR) is a non-invasive measure of endogenous insulin secretion that has not been tested as a diagnostic tool in children or in patients with diabetes duration <5 yr. We aimed to assess whether UCPCR can discriminate type 1 diabetes from MODY and type 2 in pediatric diabetes.
Description
Citation
Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes. 2013, 14 (3):181-8 Pediatr Diabetes
Publisher
Wiley
License
Archived with thanks to Pediatric diabetes
Journal
Pediatric diabetes
Volume
Issue
PubMed ID
ISSN
1399-5448
EISSN